GENE ONLINE|News &
Opinion
Blog

2017-11-03|

November 3, 1950: American Biochemist James Rothman was Born

by GeneOnline
Share To

James Rothman (November 3, 1950 – present) is an American biochemist. He is the Fergus F. Wallace Professor of Biomedical Sciences at Yale University and the Chairman of the Department of Cell Biology at Yale School of Medicine. Rothman dedicates his career in studying intracellular and extracellular vesicles and the trafficking mechanism. Rothman had a great contribution in discoverying how the sac-like structures within and between cells precisely transport hormones, growth factors, and other molecules to correlated destination. Rothman jointly received the 2013 Nobel Prize in Physiology or Medicine with Randy Schekman and Thomas C. Südhof for their work on vesicle trafficking. He has also received many other honors, including the King Faisal International Prize in 1996, the Louisa Gross Horwitz Prize from Columbia University and the Albert Lasker Award for Basic Medical Research both in 2002.

Reference

https://www.nobelprize.org/nobel_prizes/medicine/laureates/2013/rothman-bio.html https://en.wikipedia.org/wiki/James_Rothman

Image Source

http://fmri.org/commentary/

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
R&D
Vaccine Development Has No Limits, the Application Direction of mRNA After the Nobel Prize
2023-10-17
Svante Pääbo Wins Physiology or Medicine Nobel Prize for Human Evolution Discoveries
2022-10-06
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top